For the Inventor, By the Inventor

Enter inventor name

San Mateo, CA, United States of America

Jianming Bao

USPTO Granted Patents = 40 (Patent Applications = 10)

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 8 (Patent Applications = 21)

Average Co-Inventor Count = 6.9

ph-index = 10

Forward Citations = 224(Granted Patents)

Location History:

Westfield, NJ (US) (1997 - 1999)
Scotch Plains, NJ (US) (1999 - 2011)
Shanghai, CN (2017 - 2019)
San Mateo, CA (US) (2021 - 2022)
Princeton, NJ (US) (2012 - 2024)
South San Francisco, CA (US) (2021 - 2024)

Company Filing History:

21 out of 2,405

Merck Sharp + Dohme Corp.

19 out of 4,770

Merck + Co., Inc.

Msd R&d (china) Co., Ltd.

Metabasis Therapeutics, Inc.

Merck Msd (r&d) China Co., Ltd.

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Plasma Kallikrein Inhibitors

Diacylglyceride O-Acyltransferase 2 Inhibitors

Allosteric Modulators

M4 Muscarinic Acetylcholine Receptor

TrkA Kinase Inhibitors

Spirocyclic CETP Inhibitors

Cyclic Benzimidazole Derivatives

Anti-Diabetic Agents

Potassium Channel Inhibitors

Chemokine Receptor Activity

Immunosuppressant Activity

Triterpene Derivatives

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459927 - Plasma kallikrein inhibitors (2025-11-04),

2. 12448384 - Diacylglyceride O-acyltransferase 2 inhibitors (2025-10-21),

3. 12428411 - Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors (2025-09-30),

4. 12410159 - Preparation of oxindole derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors (2025-09-09),

5. 11976061 - Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitors (2024-05-07),

6. 11970479 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2024-04-30),

7. 11339156 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2022-05-24),

8. 11319298 - Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor (2022-05-03),

9. 11149036 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-10-19),

10. 10981902 - 5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-04-20),

11. 10933056 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor (2021-03-02),

12. 10329289 - 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor (2019-06-25),

13. 9815846 - TrkA kinase inhibitors, compositions and methods thereof (2017-11-14),

14. 9717714 - Spirocyclic CETP inhibitors (2017-08-01),

15. 8742110 - Spiroxazolidinone compounds (2014-06-03),

Title: Inventor Jianming Bao

Introduction: Jianming Bao is a prolific inventor based in San Mateo, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Jianming Bao holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Jianming Bao has worked with leading tech companies and research institutions, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Jianming Bao has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge sharing.

Conclusion: Jianming Bao's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…